Garbez, Nicolas http://orcid.org/0000-0002-8338-5385
Mbatchi, Litaty C.
Wallis, Steven C. http://orcid.org/0000-0002-2392-9854
Muller, Laurent http://orcid.org/0000-0002-8788-179X
Lipman, Jeffrey http://orcid.org/0000-0002-5965-9876
Roberts, Jason A. http://orcid.org/0000-0001-6218-435X
Lefrant, Jean-Yves http://orcid.org/0000-0002-7774-2497
Roger, Claire http://orcid.org/0000-0002-6055-0034
Funding for this research was provided by:
Nîmes University Hospital (LOCAL/2016/CR-01)
Article History
Accepted: 27 July 2021
First Online: 21 December 2021
Declarations
:
: This study was supported by academic funding from the Nimes University Hospital (LOCAL/2016/CR-01).
: Jeffrey Lipman received honoraria from MSD and Pfizer and also received institution support from MSD. Claire Roger received consultancy fees from MSD, Pfizer, and Fresenius Medical Care. Nicolas Garbez, Litaty C. Mbatchi, Steven C. Wallis, Laurent Muller, Jason A. Roberts, and Jean-Yves Lefrant have no conflicts of interest to declare.
: Ethics approval was obtained from the local ethics committee of Nîmes (Comité de Protection des Personnes Sud-Méditerranée III 2012.02.05).
: Written informed consent was obtained from either the patient or their designated substitute decision maker.
: Pmetrics software package for R (Los Angeles, CA, USA) [CitationRef removed, CitationRef removed].
: CR, J-YL, and LM conceived and designed the study. CR collected data and SCW performed drug assay. NG, CR, J-YL, and JAR analysed data. NG carried out the pharmacokinetic analysis. NG, CR and LM drafted the manuscript. All authors read and approved the final manuscript.
: All patients provided consent for publication of their pooled, anonymized data.
: The datasets analysed during the current study are available from the corresponding author on reasonable request.